|
Timothy Lynch has been a director of the Company since late 2006. He is the President and Chief Executive Officer of NeuroStat Pharmaceuticals Inc. and currently serves on the board of directors of Allos Therapeutics Inc. and BioForm Medical. In 2005 Mr. Lynch was the President and Chief Executive Officer of Vivo Therapeutics Inc. a start-up specialty pharmaceutical company. From 2002 through 2005 Mr. Lynch served as a Senior Vice President Finance and Administration and Chief Financial Officer of Tercica Inc. a public biotechnology company. From 1999 to 2002 Mr. Lynch served as Vice President Finance and Administration and Chief Financial Officer of Intermune Inc. a public biotechnology company. Mr. Lynch graduated from Colgate University with a B.A. in Economics as well as from the Harvard University Graduate School of Business Administration with a Masters in Business Administration. | 